과제정보
연구 과제 주관 기관 : National Research Foundation (NRF), Korean Ministry of Health and Welfare
참고문헌
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. https://doi.org/10.1002/ijc.29210
- Ghiringhelli F, Hennequin A, Drouillard A, Lepage C, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study. Dig Liver Dis 2014; 46: 854-8. https://doi.org/10.1016/j.dld.2014.05.011
- Kaibara N, Koga S, Jinnai D. Synchronous and metachronous malignancies of the colon and rectum in Japan with special reference to a coexisting early cancer. Cancer 1984; 54: 1870-4. https://doi.org/10.1002/1097-0142(19841101)54:9<1870::AID-CNCR2820540917>3.0.CO;2-5
- Lam AK, Chan SS, Leung M. Synchronous colorectal cancer: clinical, pathological and molecular implications. World J Gastroenterol 2014; 20: 6815-20. https://doi.org/10.3748/wjg.v20.i22.6815
- Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous colorectal carcinoma: clinico-pathological features and prognosis. Jpn J Clin Oncol 2003; 33: 38-43. https://doi.org/10.1093/jjco/hyg010
- Yang J, Peng JY, Chen W. Synchronous colorectal cancers: a review of clinical features, diagnosis, treatment, and prognosis. Dig Surg 2011; 28: 379-85. https://doi.org/10.1159/000334073
- Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg 1984; 71: 941-3. https://doi.org/10.1002/bjs.1800711210
- Evers BM, Mullins RJ, Matthews TH, Broghamer WL, Polk HC Jr. Multiple adenocarcinomas of the colon and rectum: an analysis of incidences and current trends. Dis Colon Rectum 1988; 31: 518-22. https://doi.org/10.1007/BF02553724
- Fukatsu H, Kato J, Nasu JI, et al. Clinical characteristics of synchronous colorectal cancer are different according to tumour location. Dig Liver Dis 2007; 39: 40-6. https://doi.org/10.1016/j.dld.2006.07.015
- Hu H, Chang DT, Nikiforova MN, Kuan SF, Pai RK. Clinicopathologic features of synchronous colorectal carcinoma: a distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Am J Surg Pathol 2013; 37: 1660-70. https://doi.org/10.1097/PAS.0b013e31829623b8
- Kimura T, Iwagaki H, Fuchimoto S, Hizuta A, Orita K. Synchronous colorectal carcinomas. Hepatogastroenterology 1994; 41: 409-12.
- Latournerie M, Jooste V, Cottet V, Lepage C, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg 2008; 95: 1528-33. https://doi.org/10.1002/bjs.6382
- Mulder SA, Kranse R, Damhuis RA, et al. Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study. Cancer Epidemiol 2011; 35: 442-7. https://doi.org/10.1016/j.canep.2010.12.007
- Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol 2003; 8: 162-7. https://doi.org/10.1007/s10147-003-0322-z
- Wang HZ, Huang XF, Wang Y, Ji JF, Gu J. Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma. World J Gastroenterol 2004; 10: 2136-9. https://doi.org/10.3748/wjg.v10.i14.2136
- Kato T, Alonso S, Muto Y, et al. Clinical characteristics of synchronous colorectal cancers in Japan. World J Surg Oncol 2016; 14: 272. https://doi.org/10.1186/s12957-016-1027-x
- Chen HS, Sheen-Chen SM. Synchronous and “early” metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum 2000; 43: 1093-9. https://doi.org/10.1007/BF02236556
- Finan PJ, Ritchie JK, Hawley PR. Synchronous and 'early' metachronous carcinomas of the colon and rectum. Br J Surg 1987; 74: 945-7. https://doi.org/10.1002/bjs.1800741021
- Kim YJ, Kim NK, Lee KY, Sohn SK, Min JS. Clinicopathological characteristics of multiple primary colorectal cancer. J Korean Soc Coloproctol 2002; 18: 343-8.
- Kang JG, Kim DH, Kim CH, Lee SH, Choi YJ. Clinical characteristics of synchronous multiple colorectal cancer. J Korean Soc Coloproctol 2006; 22: 418-23.
- Welch JP. Multiple colorectal tumors: an appraisal of natural history and therapeutic options. Am J Surg 1981; 142: 274-80. https://doi.org/10.1016/0002-9610(81)90292-0
- Lam AK, Carmichael R, Gertraud Buettner P, Gopalan V, Ho YH, Siu S. Clinicopathological significance of synchronous carcinoma in colorectal cancer. Am J Surg 2011; 202: 39-44. https://doi.org/10.1016/j.amjsurg.2010.05.012
- Pedroni M, Tamassia MG, Percesepe A, et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer 1999; 81: 1-5. https://doi.org/10.1002/(SICI)1097-0215(19990331)81:1<1::AID-IJC1>3.0.CO;2-K
- Norrie MW, Hawkins NJ, Todd AV, Meagher AP, O'Connor TW, Ward RL. The role of hMLH1 methylation in the development of synchronous sporadic colorectal carcinomas. Dis Colon Rectum 2002; 45: 674-80. https://doi.org/10.1007/s10350-004-6266-1
- Dykes SL, Qui H, Rothenberger DA, Garcia-Aguilar J. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer. Cancer 2003; 98: 48-54. https://doi.org/10.1002/cncr.11445
- Nosho K, Kure S, Irahara N, et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609-20.e1-3. https://doi.org/10.1053/j.gastro.2009.08.002
- Gonzalo V, Lozano JJ, Alonso-Espinaco V, et al. Multiple sporadic colorectal cancers display a unique methylation phenotype. PLoS One 2014; 9: e91033. https://doi.org/10.1371/journal.pone.0091033
- Brueckl WM, Limmert T, Brabletz T, et al. Mismatch repair deficiency in sporadic synchronous colorectal cancer. Anticancer Res 2000; 20: 4727-32.
- Kamiyama H, Suzuki K, Maeda T, et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 2012; 31: 5029-37. https://doi.org/10.1038/onc.2011.652
- Eguchi K, Yao T, Konomoto T, Hayashi K, Fujishima M, Tsuneyoshi M. Discordance of p53 mutations of synchronous colorectal carcinomas. Mod Pathol 2000; 13: 131-9. https://doi.org/10.1038/modpathol.3880024
- Giannini R, Lupi C, Loupakis F, et al. KRAS and BRAF genotyping of synchronous colorectal carcinomas. Oncol Lett 2014; 7: 1532-6. https://doi.org/10.3892/ol.2014.1905
- Ronnekleiv-Kelly SM, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2017; 6: 35-43. https://doi.org/10.21037/hbsn.2016.10.02
- Enker WE, Dragacevic S. Multiple carcinomas of the large bowel: a natural experiment in etiology and pathogenesis. Ann Surg 1978; 187: 8-11. https://doi.org/10.1097/00000658-197801000-00002
- Bae JM, Kim JH, Cho NY, Kim TY, Kang GH. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer 2013; 109: 1004-12. https://doi.org/10.1038/bjc.2013.430
- Oh HJ, Bae JM, Wen XY, Cho NY, Kim JH, Kang GH. Overexpression of POSTN in tumor stroma is a poor prognostic indicator of colorectal cancer. J Pathol Transl Med 2017; 51: 306-13. https://doi.org/10.4132/jptm.2017.01.19
- Bae JM, Kim JH, Kang GH. Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway. Arch Pathol Lab Med 2016; 140: 406-12. https://doi.org/10.5858/arpa.2015-0310-RA
피인용 문헌
- Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas vol.8, pp.None, 2018, https://doi.org/10.3389/fcell.2020.00368
- Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor–Immune Microenvironment in Colorectal Cancers vol.26, pp.4, 2020, https://doi.org/10.1158/1078-0432.ccr-19-1159